322 related articles for article (PubMed ID: 9570170)
1. Cost savings in duodenal ulcer therapy through Helicobacter pylori eradication compared with conventional therapies: results of a randomized, double-blind, multicenter trial. Gastrointestinal Utilization Trial Study Group.
Sonnenberg A; Schwartz JS; Cutler AF; Vakil N; Bloom BS
Arch Intern Med; 1998 Apr; 158(8):852-60. PubMed ID: 9570170
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic therapy of Helicobacter pylori infection reduces healthcare expenditures related to duodenal ulcer.
Sonnenberg A; Pauly MP; Levenson SD; Schwartz JS
Am J Manag Care; 1999 Jan; 5(1):53-9. PubMed ID: 10345967
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori-positive duodenal ulcer: three-day antibiotic eradication regimen.
Catalano F; Branciforte G; Catanzaro R; Cipolla R; Bentivegna C; Brogna A
Aliment Pharmacol Ther; 2000 Oct; 14(10):1329-34. PubMed ID: 11012478
[TBL] [Abstract][Full Text] [Related]
4. Ranitidine bismuth citrate with clarithromycin versus omeprazole with amoxycillin in the cure of Helicobacter pylori infection.
Kolkman JJ; Tan TG; Oudkerk Pool M; Van Kleef WA; Geraedts AA; Timmerman RJ; Crobach LF; Nicolai JJ; Wolff AA; Van Der Laan J
Aliment Pharmacol Ther; 1997 Dec; 11(6):1123-9. PubMed ID: 9663840
[TBL] [Abstract][Full Text] [Related]
5. Double-blind, multicenter, placebo-controlled evaluation of clarithromycin and omeprazole for Helicobacter pylori-associated duodenal ulcer.
O'Morain C; Dettmer A; Rambow A; von Fritsch E; Fraser AG
Helicobacter; 1996 Sep; 1(3):130-7. PubMed ID: 9398893
[TBL] [Abstract][Full Text] [Related]
6. Triple therapy with ranitidine or lansoprazole in the treatment of Helicobacter pylori-associated duodenal ulcer.
Lazzaroni M; Bargiggia S; Bianchi Porro G
Am J Gastroenterol; 1997 Apr; 92(4):649-52. PubMed ID: 9128316
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of Helicobacter pylori eradication therapy in duodenal ulcer disease.
Jönsson B
Scand J Gastroenterol Suppl; 1996; 215():90-5. PubMed ID: 8722390
[TBL] [Abstract][Full Text] [Related]
8. Ranitidine bismuth citrate versus omeprazole triple therapy for the eradication of Helicobacter pylori and healing of duodenal ulcer.
Catalano F; Catanzaro R; Bentivegna C; Brogna A; Condorelli G; Cipolla R
Aliment Pharmacol Ther; 1998 Jan; 12(1):59-62. PubMed ID: 9692702
[TBL] [Abstract][Full Text] [Related]
9. Lansoprazole-based triple therapy versus ranitidine bismuth citrate-based dual therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer: a multicenter, randomized, double-dummy study.
Luzza F; Giglio A; Ciliberto E; Belmonte A; Cavaliere C; Saccà N; Frandina C; Fiocca R; Trimboli V; Pallone F
Clin Ther; 2001 May; 23(5):761-70. PubMed ID: 11394734
[TBL] [Abstract][Full Text] [Related]
10. Decision analysis of Helicobacter pylori eradication therapy using omeprazole with either clarithromycin or amoxicillin.
Craig AM; Davey P; Malek M; Murray F
Pharmacoeconomics; 1996 Jul; 10(1):79-92. PubMed ID: 10160472
[TBL] [Abstract][Full Text] [Related]
11. Comparison of ranitidine bismuth citrate plus clarithromycin with omeprazole plus clarithromycin for the eradication of Helicobacter pylori.
Paré P; Farley A; Romãozinho JM; Bardhan KD; French PC; Roberts PM
Aliment Pharmacol Ther; 1999 Aug; 13(8):1071-8. PubMed ID: 10468683
[TBL] [Abstract][Full Text] [Related]
12. Evolving therapy for Helicobacter pylori infection: efficacy and economic impact in the treatment of patients with duodenal ulcer disease.
Cutler AF; Vakil N
Am J Manag Care; 1997 Oct; 3(10):1528-34. PubMed ID: 10178459
[TBL] [Abstract][Full Text] [Related]
13. Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. RBC H. pylori Study Group.
Peterson WL; Ciociola AA; Sykes DL; McSorley DJ; Webb DD
Aliment Pharmacol Ther; 1996 Jun; 10(3):251-61. PubMed ID: 8791947
[TBL] [Abstract][Full Text] [Related]
14. The effect of antibiotic therapy on bleeding from duodenal ulcer.
Sonnenberg A; Olson CA; Zhang J
Am J Gastroenterol; 1999 Apr; 94(4):950-4. PubMed ID: 10201462
[TBL] [Abstract][Full Text] [Related]
15. Comparative treatment of Helicobacter pylori-positive duodenal ulcer using pantoprazole at low and high doses versus omeprazole in triple therapy.
Catalano F; Branciforte G; Catanzaro R; Bentivegna C; Cipolla R; Nuciforo G; Brogna A
Helicobacter; 1999 Sep; 4(3):178-84. PubMed ID: 10469192
[TBL] [Abstract][Full Text] [Related]
16. Seven-day triple therapy with ranitidine bismuth citrate or omeprazole and two antibiotics for eradication of Helicobacter pylori in duodenal ulcer: a multicentre, randomized, single-blind study.
Spinzi GC; Boni F; Bortoli A; Colombo E; Ballardini G; Venturelli R; Minoli G
Aliment Pharmacol Ther; 2000 Mar; 14(3):325-30. PubMed ID: 10735926
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the cost-effectiveness of Helicobacter pylori eradication triple therapy vs. conventional therapy for ulcers in Japan.
Ikeda S; Tamamuro T; Hamashima C; Asaka M
Aliment Pharmacol Ther; 2001 Nov; 15(11):1777-85. PubMed ID: 11683692
[TBL] [Abstract][Full Text] [Related]
18. Twice-daily, 10-day triple therapy with omeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in duodenal ulcer disease: results of three multicenter, double-blind, United States trials.
Laine L; Suchower L; Frantz J; Connors A; Neil G
Am J Gastroenterol; 1998 Nov; 93(11):2106-12. PubMed ID: 9820381
[TBL] [Abstract][Full Text] [Related]
19. Omeprazole versus ranitidine: short-term triple-therapy in patients with Helicobacter pylori-positive duodenal ulcers.
Spadaccini A; De Fanis C; Sciampa G; Masciulli V; Pantaleone U; Di Virgilio M; Magnarini C; Pizzicannella G
Aliment Pharmacol Ther; 1996 Oct; 10(5):829-31. PubMed ID: 8899094
[TBL] [Abstract][Full Text] [Related]
20. Ranitidine bismuth citrate plus clarithromycin 7-day regimen is effective in eradicating Helicobacter pylori in patients with duodenal ulcer.
Pozzato P; Zagari M; Cardelli A; Catalano FA; Giglio A; Lami F; Pilotto A; Scarpulla G; Spadaccini A; Susi D; Tosatto R; Olivieri A; Bazzoli F; Roda E
Aliment Pharmacol Ther; 1998 May; 12(5):447-51. PubMed ID: 9663724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
